CIK 0000784199 · Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592417093
- Phone
- 7704193355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Davis John E Chief Commercial Officer | Sale | −5,000 | $45.11 | $226K | 193,842 |
| 2025-12-08 | Horton Amy VP, Chief Accounting Officer | Sale | −4,572 | $44.42 | $203K | 130,058 |
| 2025-12-03 | Mackin James P President & CEO | Option exercise 10b5-1 | +30,921 | $29.62 | $916K | 831,914 |
| 2025-12-03 | Mackin James P President & CEO | Sale 10b5-1 | −30,921 | $45.46 | $1.4M | 800,993 |
| 2025-12-03 | Mackin James P President & CEO | Option exercise · Stock Options (Right to buy) 10b5-1 | −30,921 | 0 | ||
| 2025-12-03 | Holloway Jean F SVP, General Counsel | Sale | −2,048 | $45.30 | $93K | 161,360 |
| 2025-12-03 | Holloway Jean F SVP, General Counsel | Sale | −5,267 | $45.30 | $239K | 156,093 |
| 2025-12-02 | Mackin James P President & CEO | Option exercise 10b5-1 | +30,921 | $29.62 | $916K | 831,914 |
| 2025-12-02 | Mackin James P President & CEO | Sale 10b5-1 | −30,921 | $45.56 | $1.4M | 800,993 |
| 2025-12-02 | Mackin James P President & CEO | Option exercise · Stock Options (Right to buy) 10b5-1 | −30,921 | 0 | ||
| 2025-12-01 | Horton Amy VP, Chief Accounting Officer | Gift | −750 | 134,630 | ||
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Option exercise | +20,301 | $18.44 | $374K | 65,054 |
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −14,586 | $44.92 | $655K | 50,468 |
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −5,715 | $45.35 | $259K | 44,753 |
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Option exercise | +27,075 | $11.03 | $299K | 71,828 |
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −18,705 | $44.91 | $840K | 53,123 |
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −8,370 | $45.35 | $380K | 44,753 |
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Option exercise · Stock Options (Right to buy) | −20,301 | 0 | ||
| 2025-11-21 | Stanton Marshall S. SVP, Clinical & MD Affair | Option exercise · Stock Options (Right to buy) | −27,075 | 0 | ||
| 2025-11-20 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −11,888 | $44.14 | $525K | 44,753 |
Page 4 of 11 · 201 trades